174 related articles for article (PubMed ID: 22183132)
1. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of droplet velocity and size from nasal spray devices using phase Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
Int J Pharm; 2010 Mar; 388(1-2):82-7. PubMed ID: 20043981
[TBL] [Abstract][Full Text] [Related]
3. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
Pu Y; Kline LC; Berry J
Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
[TBL] [Abstract][Full Text] [Related]
4. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
6. The CFC to HFA transition and its impact on pulmonary drug development.
Leach CL
Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
[TBL] [Abstract][Full Text] [Related]
7. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
8. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
9. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.
Alatrash A; Matida E
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):501-513. PubMed ID: 27504720
[TBL] [Abstract][Full Text] [Related]
11. New analytical techniques to facilitate preformulation screening in propellant systems.
Mogalian E; Kuehl PJ; Myrdal PB
Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897
[TBL] [Abstract][Full Text] [Related]
12. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
13. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
Rau JL; Torniainen M
Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
[TBL] [Abstract][Full Text] [Related]
14. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
15. A novel formulation technique for metered dose inhaler (MDI) suspensions.
Steckel H; Wehle S
Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
[TBL] [Abstract][Full Text] [Related]
16. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
17. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
Berry J; Kline LC; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
[TBL] [Abstract][Full Text] [Related]
18. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
[TBL] [Abstract][Full Text] [Related]
19. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
Ganderton D; Lewis D; Davies R; Meakin B; Church T
Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
[TBL] [Abstract][Full Text] [Related]
20. Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.
Hoe S; Young PM; Rogueda P; Traini D
AAPS PharmSciTech; 2008; 9(2):605-11. PubMed ID: 18459053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
